Evidence map›Paper›PMID 39861120›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Optimization of the Antibacterial Activity of a Three-Component Essential Oil Mixture from Moroccan

Amine Elbouzidi, Mohamed Taibi, Naoufal El Hachlafi, Mounir Haddou, Mohamed Jeddi, Abdellah Baraich, Saad Bougrine, Ramzi A Mothana, Mohammed F Hawwal, Waleed A Alobaid and 5 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Inefficacy ofAnimals : an open access journal from MDPI · 2026
    Article
  2. Article
  3. Genoprotective Properties ofInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Amine ElbouzidiLaboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.ORCID 0000-0003-0314-8484
Mohamed TaibiLaboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.ORCID 0000-0002-5682-3538
Naoufal El HachlafiFaculty of Medicine and Pharmacy, Ibn Zohr University, Guelmim 81000, Morocco.ORCID 0000-0003-0768-5914
Mounir HaddouLaboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.ORCID 0009-0007-4366-843X
Mohamed JeddiFaculty of Medicine and Pharmacy, Ibn Zohr University, Guelmim 81000, Morocco.ORCID 0000-0002-7165-1842
Abdellah BaraichLaboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed First University, Boulevard Mohamed VI, B.P. 717, Oujda 60000, Morocco.ORCID 0000-0002-7483-6738
Saad BougrineCentre de l'Oriental des Sciences et Technologies de l'Eau et de l'Environnement (COSTEE), Université Mohammed Premier, Oujda 60000, Morocco.
Ramzi A MothanaDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-4220-7854
Mohammed F HawwalDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-9192-7260
Waleed A AlobaidDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-1389-8724
Abdeslam AsehraouLaboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed First University, Boulevard Mohamed VI, B.P. 717, Oujda 60000, Morocco.ORCID 0000-0001-5195-8217
Bouchra El GuerroujLaboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.
Hanae Naceiri MrabtiHigh Institute of Nursing Professions and Health Techniques, Casablanca 20250, Morocco.ORCID 0000-0002-8145-2572
Francois MesnardBIOPI-BioEcoAgro UMRT 1158 INRAE, Université de Picardie Jules Verne, 80000 Amiens, France.
Mohamed AddiLaboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.ORCID 0000-0002-3973-6694

Funding

King Saud University RSP2025R119
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe rise of antibiotic-resistant pathogens has become a global health crisis, necessitating the development of alternative antimicrobial strategies. This study aimed to optimize the antibacterial effects of essential oils (EOs) from

methodsThis study utilized a simplex-centroid design to optimize the mixture ratios of EOs for maximal antibacterial and antioxidant effectiveness. The chemical profiles of the EOs were analyzed using gas chromatography-mass spectrometry (GC-MS). The antibacterial activity was assessed against

resultsThe optimized essential oil mixtures demonstrated potent antibacterial activity, with MIC values of 0.097% (

conclusionsThe study successfully demonstrates that optimized mixtures of EOs can serve as effective natural antibacterial agents. The findings highlight a novel approach to enhance the applications of essential oils, suggesting their potential use in food preservation and biopharmaceutical formulations. This optimization strategy offers a promising avenue to combat antibiotic resistance and enhance food safety using natural products.

Indexed as

antibacterial activitybiopharmaceuticalsessential oilsexperimental mixture designfood preservationLavandula angustifoliaOriganum majoranaThymus satureioides

Identifiers

PMID39861120
PMCPMC11769045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.